1410. Novel Framework to Compare the Effectiveness of Tazobactam, Relebactam and Avibactam Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

por Abodakpi, Henrietta, Chang, Kai-Tai, Byerly, Caitlan, Tam, Vincent
Publicado 2018

1409. Evaluation of Alternative Piperacillin–tazobactam Dosing Strategies Against ESBL-Producing Enterobacteriaceae Using a Hollowfiber Infection Model

por Abodakpi, Henrietta, Chang, Kai-Tai, Sánchez-Díaz, Ana Maria, Cantón, Rafael, Tam, Vincent
Publicado 2018

Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity

por Tran, Truc T, Diaz, Lorena, Abodakpi, Henrietta, Ardila, Javier, Cadena, Elsa De La, Rios, Rafael, Miller, William, Rivas, Lina, Dinh, An, Porras, Paola, Panesso, Diana, Tam, Vincent, Munita, Jose M, Arias, Cesar
Publicado 2017

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways

por Skoglund, Erik, Abodakpi, Henrietta, Rios, Rafael, Diaz, Lorena, De La Cadena, Elsa, Dinh, An Q., Ardila, Javier, Miller, William R., Munita, Jose M., Arias, Cesar A., Tam, Vincent H., Tran, Truc T.
Publicado 2018

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”

por Skoglund, Erik, Abodakpi, Henrietta, Rios, Rafael, Diaz, Lorena, De La Cadena, Elsa, Dinh, An Q., Ardila, Javier, Miller, William R., Munita, Jose M., Arias, Cesar A., Tam, Vincent H., Tran, Truc T.
Publicado 2019